Atlas Trials

ER+ Breast Cancer

26 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch ER+ Breast Cancer

RecordFirmDate
A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer (NCT04985266)Royal Marsden NHS Foundation Trust2022-03-30
Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) (NCT04551495)Jules Bordet Institute2021-01-14
4FMFES-PET Imaging of ER+ Advanced Breast Cancers (NCT04824014)Centre de recherche du Centre hospitalier universitaire de Sherbrooke2020-11-01
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer (NCT04174352)University of Wisconsin, Madison2020-10-20
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer (NCT04360941)Royal Marsden NHS Foundation Trust2020-08-11
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. (NCT03983954)NeoTX Therapeutics Ltd.2019-10-10
Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen Levels (NCT04312347)Nalagenetics Pte Ltd2019-09-06
CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) (NCT02580448)Innocrin Pharmaceutical2015-08-01
Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing (NCT00828854)Syndax Pharmaceuticals2008-10-01
Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer (NCT00676663)Syndax Pharmaceuticals2008-06-13

Track ER+ Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.